Henk-jan J. Westeneng

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications

Diagnostic Revision From Primary Lateral Sclerosis to Amyotrophic Lateral Sclerosis: A Cohort Study.

Diagnostic Revision From Primary Lateral Sclerosis to Amyotrophic Lateral Sclerosis: A Cohort Study.

Journal: Neurology
Published: May 29, 2026

Prodromal symptoms in amyotrophic lateral sclerosis from the perspective of the patient and of the caregiver.

Prodromal symptoms in amyotrophic lateral sclerosis from the perspective of the patient and of the caregiver.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: October 25, 2025

Brain Sphingolipid and Phospholipid Levels Are Altered in XK Disease.

Brain Sphingolipid and Phospholipid Levels Are Altered in XK Disease.

Journal: Movement disorders : official journal of the Movement Disorder Society
Published: September 08, 2025

Small RNA sequencing identifies serum tDR-1:34-Gly-GCC tiRNA levels as a biomarker for survival in amyotrophic lateral sclerosis.

Small RNA sequencing identifies serum tDR-1:34-Gly-GCC tiRNA levels as a biomarker for survival in amyotrophic lateral sclerosis.

Journal: iScience
Published: August 15, 2025

Altered EEG Response of the Parietal Network in Asymptomatic C9orf72 Carriers.

Altered EEG Response of the Parietal Network in Asymptomatic C9orf72 Carriers.

Journal: Human brain mapping
Published: March 06, 2025

Multimodal Neuroimaging-Guided Stratification in Amyotrophic Lateral Sclerosis Reveals Three Disease Subtypes: A Multi-Cohort Analysis.

Multimodal Neuroimaging-Guided Stratification in Amyotrophic Lateral Sclerosis Reveals Three Disease Subtypes: A Multi-Cohort Analysis.

Journal: Human brain mapping
Published: February 27, 2025

Cognitive impairment within and beyond the FTD spectrum in ALS: development of a complementary cognitive screen.

Cognitive impairment within and beyond the FTD spectrum in ALS: development of a complementary cognitive screen.

Journal: Journal of neurology
Published: December 30, 2024

Patterns of altered in vivo brain metabolism in patients with amyotrophic lateral sclerosis (ALS) and asymptomatic C9orf72 mutation carriers: a cross-sectional 1H and 31P magnetic resonance spectroscopic 7T imaging study.

Patterns of altered in vivo brain metabolism in patients with amyotrophic lateral sclerosis (ALS) and asymptomatic C9orf72 mutation carriers: a cross-sectional 1H and 31P magnetic resonance spectroscopic 7T imaging study.

Journal: EBioMedicine
Published: September 23, 2024

Molecular pathology, developmental changes and synaptic dysfunction in (pre-) symptomatic human C9ORF72-ALS/FTD cerebral organoids.

Molecular pathology, developmental changes and synaptic dysfunction in (pre-) symptomatic human C9ORF72-ALS/FTD cerebral organoids.

Journal: Acta neuropathologica communications
Published: August 21, 2024

Neuroimaging correlates of domain-specific cognitive deficits in amyotrophic lateral sclerosis.

Neuroimaging correlates of domain-specific cognitive deficits in amyotrophic lateral sclerosis.

Journal: NeuroImage. Clinical
Published: July 31, 2024

Association Between Hypothalamic Volume and Metabolism, Cognition, and Behavior in Patients With Amyotrophic Lateral Sclerosis.

Association Between Hypothalamic Volume and Metabolism, Cognition, and Behavior in Patients With Amyotrophic Lateral Sclerosis.

Journal: Neurology
Published: June 14, 2024

Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS/FTD.

Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS/FTD.

Journal: Journal of neurology, neurosurgery, and psychiatry
Published: May 29, 2024
Showing 1-12 of 53

Last Updated: 09/26/2026